116 related articles for article (PubMed ID: 9209249)
1. Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels.
Stein CM; Brown N; Carlson MG; Campbell P; Wood AJ
Clin Pharmacol Ther; 1997 Jun; 61(6):662-8. PubMed ID: 9209249
[TBL] [Abstract][Full Text] [Related]
2. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
Pratz J; Mondot S; Montier F; Cavero I
J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
[TBL] [Abstract][Full Text] [Related]
4. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
5. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
6. Effect of ATP sensitive potassium channel modifiers on antinociceptive effect of metoclopramide.
Reddy PM; Shantanu S; Shewade DG; Ramaswamy S
Indian J Exp Biol; 2001 May; 39(5):476-8. PubMed ID: 11510133
[TBL] [Abstract][Full Text] [Related]
7. Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis.
Zhang Y; Zhou J; Corll C; Porter JR; Martin RJ; Roane DS
Eur J Pharmacol; 2004 May; 492(1):71-9. PubMed ID: 15145709
[TBL] [Abstract][Full Text] [Related]
8. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic activity and toxicity of Zizyphus spina-christi leaves.
Abdel-Zaher AO; Salim SY; Assaf MH; Abdel-Hady RH
J Ethnopharmacol; 2005 Oct; 101(1-3):129-38. PubMed ID: 16009520
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cerebral blood flow response to insulin-induced hypoglycemia by caffeine and glibenclamide in conscious rats.
Horinaka N; Kuang TY; Pak H; Wang R; Jehle J; Kennedy C; Sokoloff L
J Cereb Blood Flow Metab; 1997 Dec; 17(12):1309-18. PubMed ID: 9397030
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
[TBL] [Abstract][Full Text] [Related]
12. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhibition of ATP-sensitive potassium channels on metabolic vasodilation in the human forearm.
Farouque HM; Meredith IT
Clin Sci (Lond); 2003 Jan; 104(1):39-46. PubMed ID: 12519086
[TBL] [Abstract][Full Text] [Related]
14. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Rosenn B
Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
Warrillow S; Egi M; Bellomo R
Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
[TBL] [Abstract][Full Text] [Related]
16. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
[TBL] [Abstract][Full Text] [Related]
17. The involvement of ATP-sensitive potassium channels in beta 2-adrenoceptor agonist-induced vasodilatation on rat diaphragmatic microcirculation.
Chang HY
Br J Pharmacol; 1997 Jul; 121(5):1024-30. PubMed ID: 9222563
[TBL] [Abstract][Full Text] [Related]
18. The influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjects.
Boni JP; Cevallos WH; DeCleene S; Korth-Bradley JM
Pharmacotherapy; 1997; 17(4):783-90. PubMed ID: 9250558
[TBL] [Abstract][Full Text] [Related]
19. No role of calcium- and ATP-dependent potassium channels in insulin-induced vasodilation in humans in vivo.
Abbink EJ; Walker AJ; van der Sluijs HA; Tack CJ; Smits P
Diabetes Metab Res Rev; 2002; 18(2):143-8. PubMed ID: 11994906
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
Bavirti S; Tayek JA
Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
